A Single Blind Randomised Controlled Clinical Study to evaluate the Varnya and Medhya effect of Yastimadhu ghrita over Manjishta ghrita internally and externally in Mukha Vyanga with special reference to Melasma - NI

DrSapna Xavier Lopes0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年6月24日

试验速览

暂无简介。

•Classical signs and symptoms of Vyanga like Shyava(brown coloured patches), tanuka(thin,non elevated), niruja(painless) mandalas on mukha, with or without kandu or daha or chimchimata associated with or without manasika hetus.
•Subjects willing to participate and comply with all study procedures for prescribed trial period.
•Subjects willing to give a written consent.
•Age group between 18-55 yrs of either sex.
•Subject not using any topical treatment for melasma for 2 weeks prior to enrolment to the study.

•Any medical conditions, laboratory findings or physical examination findings like vital signs, outside of specific range.
•If subject is on any concomitant medications like oral contraceptives, thyroid medications and hormone replacement therapies.
•Known allergic reaction to component of study product.
•Treatment with other investigatory drug or other intervention within a specific time frame.
•H/O drug or alcohol abuse.
•Pregnant and lactating women.
•Subject who have taken topical or oral steroids within 1 month prior to enrolment.
•Subject who have taken topical tretinoin within 3 months or topical hydroquinone within 6 months prior to enrolment.
•Subject under treatment of another dermatological condition.
•Post Inflammatory Hyperpigmentation(PIH).

发起方

DrSapna Xavier Lopes